Terminix Completes Divestment of U.K. and Norway Businesses

Completion of the divestment and the previously announced completion of the antitrust review process in the U.S. will satisfy two of the closing conditions to the company's pending merger with Rentokil. Remaining conditions to be satisfied include approval by the company’s and Rentokil’s shareholders, and the registration of Rentokil’s American depository shares with the U.S. Securities and Exchange Commission and their listing on the New York Stock Exchange. Both parties continue to make good progress on satisfying these remaining conditions and the transaction remains on track for completion in the second half of 2022, with a targeted closing by the end of the third quarter.

Paul Giannamore and Franco Villanueva-Meyer of The Potomac Company advised Terminix on these transactions.